| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥6.60B | +37.9% |
| Gross profit | ¥1.92B | — |
| Operating income | ¥0.94B | — |
| Net income | ¥0.85B | +73.0% |
| Gross margin | 29.2% | Net margin 12.9% |
| Revenue Q/Q | -4.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥4.67B | 70.8% |
| R&D | ¥0.40B | 6.1% |
| SG&A | ¥0.40B | 6.1% |
| Tax & other | ¥0.09B | 1.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
德赛西威 ・ 鹏鼎控股 ・ 中国广核 ・ 亿纬锂能 ・ 爱尔眼科 ・ 同花顺 ・ 东方财富 ・ 智飞生物 ・ 汇川技术 ・ 光线传媒 ・ 阳光电源 ・ 中际旭创
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies